MedTrace Logo

Recurrent Atrial Fibrillation

NCT02898545 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2017-08-01

No results posted yet for this study

Summary

This study will evaluate the recurrence rates of atrial fibrillation that develops in the hospital following non cardiac procedures or surgeries or acute medical illnesses.

Conditions

Interventions

DEVICE

SEEQ monitor

An external cardiac rhythm monitor

Sponsors & Collaborators

  • University of Cincinnati

    lead OTHER

Principal Investigators

  • Mehran Attari, MD · University of Cincinnati

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-07-20
Completion
2017-07-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02898545 on ClinicalTrials.gov